Skip to main content
Clinical Trials/CTRI/2025/02/081174
CTRI/2025/02/081174
Not yet recruiting
Not Applicable

Comparison of ropivacaine with and without dexmedetomidine in infraclavicular brachial plexus block for postoperative analgesia in forearm surgeries

D Sanitha kumari1 site in 1 country40 target enrollmentStarted: March 7, 2025Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
D Sanitha kumari
Enrollment
40
Locations
1
Primary Endpoint
1. Time for rescue analgesia

Overview

Brief Summary

Summary:

This prospective, comparative study evaluates the efficacy of ropivacaine with and without dexmedetomidine for infraclavivular brachial plexus block in forearm surgeries, focusing on post-operative analgesia

Methodology:The patients are randomised into two groups (Group A and Group B) of 20 patients each using computer generated random number method. Group A patients will receive Plain 0.75% Ropivacaine and Group B patients will receive 0.75% Ropivacaine with 1μg/kg Dexmedetomidine

The following parameters will be recorded post-operatively at fixed time intervals:

-vas score

-Ramsay sedation score

-time for rescue analgesia

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Participant, Investigator and Outcome Assessor Blinded

Eligibility Criteria

Ages
16.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patient not giving consent Local skin infections Significant cardiac disease and patients on beta blockers.
  • Suspected coagulopathy or bleeding diathesis Allergy to local anesthetics and study drug.
  • Psychiatric Illness Chronic preoperative opioid consumption Procedure posted for other than supine position.

Outcomes

Primary Outcomes

1. Time for rescue analgesia

Time Frame: Measured post-operatively at regular intervals 0,4,8,12,16,20,24hours

Secondary Outcomes

  • 1. Visual analog scale (VAS) score(2. Ramsay sedation score)

Investigators

Sponsor
D Sanitha kumari
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

D Sanitha kumari

Dr. D.Y.Patil hospital and research center

Study Sites (1)

Loading locations...

Similar Trials